Erzincan, 2015 I ABSTRACTS INVITED LECTURERS IL - 1. GENERATIONS @ WORK __________________________________________________________ 8 IL - 2. NANOMATERIALS IN COSMETICS ____________________________________________________ 9 IL - 3. FEATURE-BASED 3D PHARMACOPHORE MODELS: EFFICIENT MEDICINAL CHEMISTRY DECISION SUPPORT TOOLS ________________________________________________________________ 10 IL - 4. COLLOIDAL CARRIERS AT BIOLOGICAL BARRIERS: CHALLENGES AND NEW CONCEPTS FOR DERMAL AND PULMONARY APPLICATION ___________________________________________________ 11 IL - 5. “HOW A MOLECULE CAN BE CALLED AS A MEDICINAL PRODUCT”: REGISTRATION PROCEDURES IN TURKEY _______________________________________________________________________ 12 IL - 6. RESEARCH AND DEVELOPMENT ACTIVITIES IN PHARMACEUTICAL SECTOR FROM AN ACADEMICIAN POINT OF VIEW ________________________________________________________________ 13 IL - 7. TOXİCİTY OF MYCOTOXİNS _______________________________________________________ 14 IL - 8. NEW HORIZONS IN NANOTHERAPEUTICS: NANOTUBES, QUANTUM DOTS, LIPID BASED CARRIERS, NANOVAULTS, NANOBOATS ______________________________________________________ 15 IL - 9. APPLICATION OF NEW NANO-BASED ELECTROCHEMICAL AND SPECTROSCOPIC SENSORS IN PHARMACEUTICAL ANALYSIS ______________________________________________________ 17 IL - 10. ACTUAL ASPECTS OF THE GLOBAL MARKET OF MEDICAL COSMETICS ______________________ 19 IL - 11. TOXICITY OF DRUG _________________________________ HATA! YER İŞARETİ TANIMLANMAMIŞ. ORAL PRESENTATIONS OP - 1. QUALITY CONTROL OF HERBAL MEDICINES BY CAPILLARY ELECTROPHORESIS COUPLED WITH LASER INDUCED FLUORESCENCE DETECTOR _______________________________________________ 21 OP - 2. TRANSFER OF ADVANCED KNOWLEDGE AND TECHNOLOGIES TO MODERN-DAY EDUCATION ___ 22 OP - 3. CHEMOMETRIC SIGNAL PROCESSING METHODS IN DRUG ANALYSIS _______________________ 23 OP - 4. LIPOSOME FORMULATIONS FOR COSMETIC TEXTILE APPLICATIONS _______________________ 24 OP - 5. PREPARATION AND EVALUATION OF NOVEL MICROEMULSION-BASED HYDROGELS FOR DERMAL DELIVERY OF BENZOCAINE ________________________________________________________ 25 OP - 6. IMPLEMENTATION OF CLINICAL PHARMACY PRACTICES IN HACETTEPE HOSPITALS? __________ 26 OP - 7. HOW MUCH PROGRESS HAS PSYCHIATRY MADE IN THE LAST CENTURY? DO WE KNOW ENOUGH ABOUT THE HUMAN PSYCHE TO PRESCRIBE THE MEDICATION?_____________ 27 OP - 8. HUMAN MEDICINES REGISTRATION PROCESS IN TURKEY ________________________________ 28 OP - 9. THE PHARMACY MANAGEMENT DEPARTMENT’S STUDIES IN TURKEY ______________________ 29 OP - 10. ANTIMUTAGENIC POTENTIALS OF FLAVONOIDS FROM ACHILLEA MILLEFOLIUM L. AND ACHILLEA BIEBERSTEINII AFAN. ____________________________________________________________ 30 OP - 11. STABILITY INDICATING HPLC-PDA ANALYSIS OF FEBUXOSTAT UTILIZING DESIGN OF EXPERIMENTS 31 OP - 12. KOZMETİK SEKTÖRÜNÜN ENDÜSTRİYEL AÇIDAN DEĞERLENDİRİLMESİ _____________________ 32 OP - 13. FORMULATION AND EVALUATIONS OF BETA CYCLODEXTRIN AND POLYETHYLENE GLYCOL MEDIATED BINARY AND TERNARY COMPLEXES OF SYLIMARINE __________________________ 33 OP - 14. FILM COATING OF TABLETS _______________________________________________________ 34 II OP - 15. PROTECTIVE ROLE OF OLEUROPEIN ON ZNOTIO2 NANOCOMPOSITE- INDUCED SOME DEVELOPMENTAL TOXICITY ON DROSOPHILA MELANOGASTER ___________________________ 35 OP - 16. TAURINE IMPROVES CHEMOTHERAPY INDUCED GASTROINTESTINAL TOXICITY IN ACUTE LYMPHOBLASTIC LEUKEMIA. ______________________________________________________ 36 OP - 17. ANTIBREASTCANCER ACTIVITY OF NANOPROPOLIS INDONESIA ON INDUCED MAMMARY TUMOR GLAND BY DMBA IN VIRGIN SPRAGUE-DAWLEY RATS __________________________________ 37 OP - 18. IN VITRO EVALUATION OF THE POTENTIAL OF PREACTIVATED POLY ( ACRYLIC ACID) THIOMERS TO INHIBIT MRP2 EFFLUX TRANSPORTER ______________________________________________ 38 OP - 19. UV-SPECTROPHOTOMETRIC-ASSISTED CHEMOMETRIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE IN PHARMACEUTICAL FORMULATIONS ________________________________________________ 39 OP - 20. SECONDARY METABOLITES OF CULTIVATED ARTEMISIA DRACUNCULUS L. __________________ 40 OP - 21. EFFECT OF AGING, EXERCISE AND CATALASE OVEREXPRESSION ON VARIOUS PROTEIN OXIDATION PRODUCTS IN MICE ____________________________________ 41 OP - 22. DETERMINATION OF IN-VITRO ANTIOXIDANT CAPACITY OF Β - AGONISTS __________________ 42 OP - 23. DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR DETERMINATION OF HALOPERIDOL IN HUMAN PLASMA _______________________________________________________________ 43 OP - 24. LABEL-FREE SENSING PLATFORM FOR DETECTION OF CHOLESTEROL ______________________ 44 POSTER PRESENTATIONS PP - 1. CYTOTOXIC EFFECT OF HELIX ASPERSA EXTRACT ON HUMAN BREAST CANCER CELL LINE HS578T 46 PP - 2. DETERMINATION OF FRUCTOSE IN SWEETENED FOODS AND BEVERAGES __________________ 47 PP - 3. DEVELOPMENT OF TECHNOLOGY AND DOSAGE FORM DESIGN FOR TARGETED DRUG DELIVERY 48 PP - 4. TAURINE IMPROVES CARBAMAZEPINE INDUCED DROWSINESS. __________________________ 49 PP - 5. "ANTI-ASTHMATIC ACTIVITY OF EUPHORBIA GRANDIALATA R. CULTIVATED IN EGYPT" ________ 50 PP - 6. DETERMINATION OF DABIGATRAN IN PHARMACEUTICAL PREPARATIONS BY DIFFERENTIAL PULSE VOLTAMMETRIC METHOD ________________________________________________________ 51 PP - 7. DETERMINATION OF SOME METAL LEVELS IN MULTIVITAMIN PREPARATIONS WITH ICP-OES AFTER DRY, WET AND MICROWAVE DIGESTION METHODS ____________________________________ 52 PP - 8. LIPOIDAL MATTERS, FLAVONOID CONTENT AND HYPOLIPIDEMIC ACTIVITY OF SPINACH ROOTS AND FLOWERS _____________________________________________________________________ 53 PP - 9. ANTIOXIDANT AND ANTIMICROBIAL ACTIVITIES OF LEPIDIUM SATIVUM EXTRACTS ___________ 54 PP - 10. DESIGN, SYNTHESIS AND CYTOTOXIC ACTIVITY EVALUATIONS OF N-HETROARYL DICHLOROACETAMIDE DERIVATIVES AS ANTICANCER AGENTS ___________________________ 55 PP - 11. SAFETY ASSESSMENT OF OSTHOLE ISOLATED FROM PRANGOS FERULACEA: ACUTE AND SUBCHRONIC TOXICITIES AND MODULATION OF CYTOCHROME P450 _____________________ 56 PP - 12. STABILIZATION OF AMORPHOUS CANDESARTAN CILEXETIL AS AN APPROACH TO INCREASE ITS AQUEOUS SOLUBILITY ___________________________________________________________ 57 PP - 13. SYNTHESIS AND ANTIMICROBIAL EVALUATION OF NEW 3-ALKYL(ARYL)-4-(2-PHENYLACETOXY-3- ETHOXYBENZYLIDENAMINO)-4,5-DIHIDRO-1H-1,2,4-TRIAZOL-5-ONES* ____________________ 58 III PP - 14. EFFECT OF OZONE ON REMOTE ORGAN INJURY IN RATS WITH HEPATIC ISCHEMIA-REPERFUSION INJURY _______________________________________________________________________ 59 PP - 15. DEVELOPMENT OF A NANOEMULSION FORMULATION OF WILD OREGANO ESSENTIAL OIL _____ 60 PP - 16. ELECTRO-OXIDATION BEHAVIOR OF DEXAMETHASONE ON THE MODIFIED-MULTI WALLED CARBON NANOTUBE ELECTRODE AND ITS APPLICATION TO BIOLOGICAL SAMPLES __________________ 61 PP - 17. HIGHLY EFFICIENT, ONE POT, SOLVENT FREE ACCESS TO SOME NOVEL QUINAZOLINONE DERIVATIVES USING PTSA (P-TOLUENESULFONIC_ACID) AS CATALYST: SYNTHESIS AND ANTIFUNGAL ACTIVITY EVALUATION ________________________________________________ 62 PP - 18. SIMULTANEOUS DETERMINATION OF CLORSULON AND IVERMECTIN IN VETERINARY INJECTABLE PREPARATION BY A NEW UPLC METHOD ____________________________________________ 63 PP - 19. CHEMICAL COMPOSITION OF LIMONIUM THOUINII (VIV.) KUNTZE (PLUMBAGINACEAE) AND THE DPPH FREE RADICAL SCAVENGING ACTIVITY __________________________________________ 64 PP - 20. FORMULATION AND EVALUATION OF KETOCONAZOLE LIPOSOMES USING INJECTION METHOD _ 65 PP - 21. DEVELOPMENT AND VALIDATION OF AN UV SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF CAPSAICIN IN THE RED HOT CHILLI PEPPER __________________________ 66 PP - 22. DEVELOPMENT AND VALIDATION OF A VIS SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF TOTAL PHENOLIC COMPOUNDS IN THE RED HOT CHILLI PEPPER _________ 67 PP - 23. AN INVESTIGATION ON PROTECTIVE EFFECT OF GILABURU (VIBURNUM OPULUS L.) FRUIT AGAINST ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE STRESS AFTER LUNG TRANSPLANTATION IN RAT 68 PP - 24. APITERAPY ____________________________________________________________________ 69 PP - 25. ENTOMOTHERAPY AND TURKEY ___________________________________________________ 70 PP - 26. THE POTENTIAL OF ARTHROPODS CAUSES VENOM ALLERGY AT TURKEY ___________________ 71 PP - 27. DIABETES MELLITUS AND ASSOCIATED FACTORS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS AT JIMMA UNIVERSITY SPECIALIZED HOSPITAL, SOUTHWEST ETHIOPIA _________ 72 PP - 28. DETERMINATION TOXIC EFFECT OF NEW SYNTHESIZE CHEMICAL COMPOUNDS IN VITRO. _____ 73 PP - 29. GENOTOXIC AND ANTIGENOTOXIC EFFECT OF NEW SYNTHESIZE CHEMICAL COMPOUNDS ON HUMAN LYMPHOCYTE IN VITRO. ___________________________________________________ 74 PP - 30. ACTIVATORS OF CARBONIC ANHYDRASE I AND II: OSAJIN AND POMIFERIN _________________ 75 PP - 31. GENOTOXIC AND ANTIGENOTOXIC EFFECT OF SOME LICHENS____________________________ 76 PP - 32. DETERMINATION OF ANTIOXIDANT CAPACITY OF TWO LICHENS IN VITRO __________________ 77 PP - 33. THE POTENTIAL OF PLANTS ARE IMPORTANT IN TERMS OF IMPLICATION THE HONEY, POLLEN, PROPOLIS USED IN APITHERAPY ___________________________________________________ 78 PP - 34. DETERMINATION OF GENOTOXIC AND ANTIGENOTOXIC EFFECT OF NEW SYNTHESIZE ORGANIC COMPOUNDS __________________________________________________________________ 79 PP - 35. DETERMINATION OF CYTOTOXIC AND ANTICYTOTOXIC EFFECT OF NEW SYNTHESIZE CONPOUNDS _____________________________________________________________________________ 80 PP - 36. GENOTOXIC AND ANTIGENOTOXIC EFFECT OF SOME LICHENS____________________________